Clinical

Dataset Information

0

Effect of an Anti-inflammatory Diet on Patients With Cervical Cancer


ABSTRACT: During radiation therapy (RT) to pelvic tumors, the small intestine, colon and rectum are inevitably included in the radiation field and are healthy tissues that suffer damage as an adverse effect. Pelvic radiation disease (PRD) is the group of gastrointestinal symptoms experienced by patients that receive pelvic radiation. Intestinal inflammation, tissue damage, oxidative stress and tumor metabolism lead the patient to a catabolic state associated with an increase in energy demands. Also, the painful abdominal symptoms restrict the patients’ food intake, leading the patients that develop PRD to an increased risk to develop protein-energy malnutrition and micronutrient deficiencies, all of which affect the patients’ quality of life. Studies developed in patients with inflammatory bowel disease have suggested that probiotics may have an anti-inflammatory effect in the intestine. In addition, micronutrients and trace elements provide antioxidant capacity and exert immune-modulating effects during periods of intestinal inflammation. Thus, probiotics and immune-modulating nutrients may provide a means to diminish intestinal inflammation and symptoms associated with PRD. In this project the investigators propose that the nutritional management of cervical cancer patients be based on an anti-inflammatory diet, taking into account the nutritional status, age, comorbidities that the patient may present and symptoms developed during treatment. The nutritional intervention will include food rich in immune-modulating nutrients: omega-3 fatty acids, soluble fiber, antioxidants and polyphenols, and probiotics.

DISEASE(S): Uterine Cervical Neoplasms,Uterine Cervical Neoplasm,Cervical Cancer,Pelvic Infection,Pelvic Inflammatory Disease,Radiation Toxicity,Diet Modification,Cancer

PROVIDER: 2308939 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

2021-08-29 | MSV000088033 | MassIVE
2013-01-01 | GSE41112 | GEO
2013-01-01 | E-GEOD-41112 | biostudies-arrayexpress
2021-04-22 | GSE152869 | GEO
2019-12-31 | GSE122671 | GEO
2023-11-10 | GSE246176 | GEO
2018-07-31 | GSE84079 | GEO
2023-06-28 | E-MTAB-10676 | biostudies-arrayexpress
| 35345 | ecrin-mdr-crc
2023-11-09 | E-MTAB-6420 | biostudies-arrayexpress